Review
doi: 10.1684/bdc.2008.0732.
[Methodological aspects on new protocols in oncology]
[Article in
French]
Affiliations
- PMID: 19004729
- DOI: 10.1684/bdc.2008.0732
Item in Clipboard
Review
[Methodological aspects on new protocols in oncology]
[Article in
French]
Bull Cancer.
2008 Oct.
Abstract
This review will summarize specific methodological aspects in targeted therapies like EPR (early progression rate) or RDD (randomized discontinuation design), along with Adaptive Design such as CRM (continual reassessment method, Eff-TOX (dose-finding based on efficacy-toxicity, PPD (predictive probability design) or ADTT (adaptive randomization for targeted therapy) methods.
Similar articles
-
[Methodological approaches of clinical studies with targeted therapies].Bull Cancer. 2008 Feb;95(2):185-90. doi: 10.1684/bdc.2008.0575. Bull Cancer. 2008. PMID: 18304903 Review. French.
-
[Continual reassessment method (CRM)].Gan To Kagaku Ryoho. 2000 Aug;27(9):1449-57. Gan To Kagaku Ryoho. 2000. PMID: 10969605 Review. Japanese.
-
Continual reassessment method: a practical design for phase 1 clinical trials in cancer.Biometrics. 1990 Mar;46(1):33-48. Biometrics. 1990. PMID: 2350571
-
Review: new biological insights in early clinical studies.Hematol Oncol. 2007 Jun;25(2):53-7. doi: 10.1002/hon.808. Hematol Oncol. 2007. PMID: 17351979 Review.
-
Practical modifications of the continual reassessment method for phase I cancer clinical trials.J Biopharm Stat. 1994 Jul;4(2):147-64. doi: 10.1080/10543409408835079. J Biopharm Stat. 1994. PMID: 7951271
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
